Protein
|
Source
|
Residues Ordered
|
Method
|
Resolution (Å)
|
Residue Map
|
Energy Map
|
PDB ID
|
Reference
|
Amyloid-β(1-42)
|
Recombinant
|
17-42
|
ssNMR
|
N/A
|
 |
 |
2beg
|
Lührs et al., 2005
|
Amyloid-β(1-40) Iowa Mutation D23N
|
Recombinant
|
15-40
|
ssNMR
|
N/A
|
 |
 |
2lnq
|
Qiang et al., 2012
|
Amyloid-β(1-40) (+)stagger
|
Recombinant
|
9-40
|
ssNMR
|
N/A
|
 |
 |
2lmn
|
Paravastu et al., 2008
|
Amyloid-β(1-40) (-)stagger
|
Recombinant
|
9-40
|
ssNMR
|
N/A
|
 |
 |
2lmo
|
Paravastu et al., 2008
|
Amyloid-β(1-40) (+)stagger
|
Recombinant
|
9-40
|
ssNMR
|
N/A
|
 |
 |
2lmp
|
Paravastu et al., 2008
|
Amyloid-β(1-40) (-)stagger
|
Recombinant
|
9-40
|
ssNMR
|
N/A
|
 |
 |
2lmq
|
Paravastu et al., 2008
|
Amyloid-β(1-40) Iowa Mutation D23N
|
Recombinant
|
15-40
|
ssNMR
|
N/A
|
 |
 |
2mpz
|
Sgourakis et al., 2015
|
Amyloid-β(1-40)
|
Recombinant, seeded from brain of a human with Alzheimers Disease
|
1-40
|
ssNMR
|
N/A
|
 |
 |
2m4j
|
Lu et al., 2013
|
Amyloid-β(1-42)
|
Recombinant
|
16-40
|
CryoEM
|
5.0
|
 |
 |
5aef
|
Schmidt et al., 2015
|
Amyloid-β(20-34)(L-isoAsp23)
|
Synthetic
|
20-34
|
MicroED
|
1.1
|
 |
 |
6nb9
|
Warmack et al., 2019
|
Amyloid-β(20-34)
|
Synthetic
|
20-34
|
MicroED
|
1.1
|
 |
 |
6oiz
|
Warmack et al., 2019
|
Amyloid-β(1-42)
|
Recombinant
|
11-42
|
ssNMR
|
N/A
|
 |
 |
2mxu
|
Xiao et al., 2015
|
Amyloid-β(1-42)
|
Recombinant
|
14-42
|
ssNMR
|
N/A
|
 |
 |
5kk3
|
Colvin et al., 2016
|
Amyloid-β(1-42)
|
Recombinant
|
14-42
|
ssNMR
|
N/A
|
 |
 |
2nao
|
Wälti et al., 2016
|
Amyloid-β(1-40) E22Δ Osaka mutation
|
Recombinant
|
1-40
|
ssNMR
|
N/A
|
 |
 |
2mvx
|
Schütz et al., 2015
|
Amyloid-β(1-42)
|
Recombinant
|
1-42
|
cryoEM
|
4.0
|
 |
 |
5oqv
|
Gremer et al., 2017
|
Amyloid-β
|
extracted from brain of a human with Alzheimers Disease (meningeal tissue)
|
1-40
|
cryoEM
|
4.4
|
 |
 |
6shs
|
Kollmer et al., 2019
|
Amyloid-β(1-40)
|
seeded with fibrils extracted from brain of a human with Alzheimers Disease (cortical tissue)
|
10-40
|
cryoEM
|
2.77
|
 |
 |
6w0o
|
Ghosh et al., 2021
|
Amyloid-β(1-40)
|
Recombinant
|
11-40
|
ssNMR
|
N/A
|
 |
 |
6ti5
|
Cerofolini et al., 2020
|
Amyloid-β(1-40 and 1-42 co-fibril)
| Recombinant
| 11-40, 11-42
| ssNMR
| N/A
|  |
 |
6ti6
|
Cerofolini et al., 2020
|
Amyloid-β(1-42)
| Type 1 fibrils extracted from the brain of a patient with Alzheimers Disease
| 9-42
| cryoEM
| 2.5
|  |
 |
7q4b
|
Yang et al., 2021
|
Amyloid-β(1-42)
| Type 2 fibrils extracted from the brain of a patient with Alzheimers Disease
| 12-42
| cryoEM
| 2.8
|  |
 |
7q4m
|
Yang et al., 2021
|
α-synuclein wt
|
Recombinant
|
43-97
|
ssNMR
|
N/A
|
 |
 |
2n0a
|
Tuttle et al., 2016
|
α-synuclein H50Q
|
Recombinant
|
36-99
|
cryoEM
|
3.3
|
 |
 |
6peo
|
Boyer et al., 2019
|
α-synuclein H50Q
|
Recombinant
|
36-99
|
cryoEM
|
3.6
|
 |
 |
6pes
|
Boyer et al., 2019
|
α-synuclein A53T
|
Recombinant
|
37-99
|
cryoEM
|
3.5
|
 |
 |
6lrq
|
Sun et al., 2020
|
α-synuclein MSA Case 2, Type II-2
|
extracted from brain of a human with Multiple Systems Atrophy (MSA)
|
14-99
|
cryoEM
|
3.1
|
 |
 |
6xyq
|
Schweighauser et al., 2020
|
α-synuclein MSA Case 2, Type II-1
|
extracted from brain of a human with Multiple Systems Atrophy (MSA)
|
14-99
|
cryoEM
|
3.3
|
 |
 |
6xyp
|
Schweighauser et al., 2020
|
α-synuclein MSA Case 1, Type I
|
extracted from brain of a human with Multiple Systems Atrophy (MSA)
|
14-99
|
cryoEM
|
2.6
|
 |
 |
6xyo
|
Schweighauser et al., 2020
|
α-synuclein N-acetylated, 1-103
|
Recombinant
|
37-96
|
cryoEM
|
3.4
|
 |
 |
6osm
|
Ni et al., 2019
|
α-synuclein rod polymorph
|
Recombinant
|
38-97
|
cryoEM
|
3.5
|
 |
 |
6cu7
|
Li et al., 2018
|
α-synuclein N-acetylated, 1-122
|
Recombinant
|
39-97
|
cryoEM
|
3.0
|
 |
 |
6osl
|
Ni et al., 2019
|
α-synuclein N-acetylated, 1-140
|
Recombinant
|
37-97
|
cryoEM
|
2.8
|
 |
 |
6osj
|
Ni et al., 2019
|
α-synuclein
|
Recombinant
|
37-99
|
cryoEM
|
3.1
|
 |
 |
6a6b
|
Li et al., 2018
|
α-synuclein (1-121)
|
Recombinant
|
38-95
|
cryoEM
|
3.4
|
 |
 |
6h6b
|
Guerrero-Ferreira et al., 2018
|
α-synuclein
|
Recombinant
|
43-83
|
cryoEM
|
3.6
|
 |
 |
6cu8
|
Li et al., 2018
|
α-synuclein polymorph 2b
|
Recombinant
|
9-24, 35-93
|
cryoEM
|
3.5
|
 |
 |
6rtb
|
Guerrero-Ferreira et al., 2019
|
α-synuclein polymorph 2b
|
Recombinant
|
14-25, 36-96
|
cryoEM
|
3.4
|
 |
 |
6sst
|
Guerrero-Ferreira et al., 2019
|
α-synuclein polymorph 2a
|
Recombinant
|
14-25, 36-95
|
cryoEM
|
3.1
|
 |
 |
6rt0
|
Guerrero-Ferreira et al., 2019
|
α-synuclein polymorph 2a
|
Recombinant
|
14-25, 36-96
|
cryoEM
|
3.0
|
 |
 |
6ssx
|
Guerrero-Ferreira et al., 2019
|
α-synuclein E46K
|
Recombinant
|
36-98
|
cryoEM
|
2.5
|
 |
 |
6ufr
|
Boyer et al., 2020
|
α-synuclein E46K
|
Recombinant
|
45-99
|
cryoEM
|
3.37
|
 |
 |
6l4s
|
Zhao et al., 2020a
|
α-synuclein phospho-Y39 twist-dimer
|
Semisynthetic
|
1-100
|
cryoEM
|
3.22
|
 |
 |
6l1t
|
Zhao et al., 2020b
|
α-synuclein phospho-Y39 twist-trimer
|
Semisynthetic
|
1-100
|
cryoEM
|
3.37
|
 |
 |
6l1u
|
Zhao et al., 2020b
|
α-synuclein wild type
| Recombinant, seeded with E46K hereditary mutation
| 46-96
| cryoEM
| 3.8
|  |
 |
7c1d
|
Long et al., 2021
|
α-synuclein G51D hereditary mutation
| Recombinant
| 50-98
| cryoEM
| 3.02
|  |
 |
7e0f
|
Sun et al., 2021
|
α-synuclein N-terminal Truncation 41-140
| Recombinant
| 46-96
| cryoEM
| 3.2
|  |
 |
7lc9
|
McGlinchey et al., 2021
|
α-synuclein Type 1A Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 2
| 37-97
| cryoEM
| 3.47
|  |
 |
7nca
|
Lovestam et al., 2021
|
α-synuclein Type 2A Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 2
| 37-97
| cryoEM
| 3.43
|  |
 |
7ncg
|
Lovestam et al., 2021
|
α-synuclein Type 1B Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 1
| 14-91
| cryoEM
| 3.84
|  |
 |
7nch
|
Lovestam et al., 2021
|
α-synuclein Type 2B Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 1
| 14-91
| cryoEM
| 3.55
|  |
 |
7nci
|
Lovestam et al., 2021
|
α-synuclein Type 2AB Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 1
| 14-91
| cryoEM
| 4.23
|  |
 |
7ncj
|
Lovestam et al., 2021
|
α-synuclein Type 3 Filaments
| Recombinant, seeded from Multiple Systems Atrophy Case 5
| 36-99
| cryoEM
| 3.18
|  |
 |
7nck
|
Lovestam et al., 2021
|
β-2-microglobulin
|
Recombinant
|
22-85
|
cryoEM
|
3.9
|
 |
 |
6gk3
|
Iadanza et al., 2018
|
β-2-microglobulin
|
Recombinant
|
20-41
|
ssNMR
|
N/A
|
 |
 |
2e8d
|
Iwata et al., 2006
|
β-endorphin
|
Recombinant
|
1-31
|
ssNMR
|
N/A
|
 |
 |
6tub
|
Seuring et al., 2020
|
CA150 WW2 Domain
|
Recombinant
|
3-33
|
ssNMR
|
N/A
|
 |
 |
2nnt
|
Ferguson et al., 2006
|
FUS LC Domain
|
Recombinant
|
37-97
|
ssNMR
|
N/A
|
 |
 |
5w3n
|
Murray et al., 2017
|
FUS LC Domain
|
Recombinant
|
112-150
|
cryoEM
|
2.62
|
 |
 |
6xfm
|
Lee et al., 2021
|
FUS LC Domain
| Recombinant
| 34-124
| cryoEM
| 2.9
|  |
 |
7vqq
|
Sun et al., 2021
|
Glucagon
|
Synthetic
|
1-29
|
ssNMR
|
N/A
|
 |
 |
6nzn
|
Gelenter et al., 2019
|
HET-s (218-289)
|
Recombinant
|
224-283
|
ssNMR
|
N/A
|
 |
 |
2rnm
|
Wasmer et al., 2008
|
hnRNPA1
|
Recombinant
|
251-295
|
cryoEM
|
2.8
|
 |
 |
7bx7
|
Sun et al., 2020
|
hnRNPA2
|
Recombinant
|
251-295
|
cryoEM
|
3.1
|
 |
 |
6wqk
|
Lu et al., 2020
|
Islet Amyloid Polypeptide (IAPP) SUMO-tagged
|
Recombinant
|
14-37
|
cryoEM
|
3.7
|
 |
 |
6vw2
|
Cao et al., 2020
|
Islet Amyloid Polypeptide (IAPP) C-term amidated
|
Synthetic
|
13-37
|
cryoEM
|
4.2
|
 |
 |
6y1a
|
Roeder et al., 2020
|
Islet Amyloid Polypeptide (IAPP) C-term amidated
|
Synthetic
|
13-37
|
cryoEM
|
3.6
|
 |
 |
6zrf
|
Gallardo et al., 2020
|
Islet Amyloid Polypeptide (IAPP) C-term amidated S20G mutant
|
Synthetic
|
15-37
|
cryoEM
|
3.9
|
 |
 |
6zrq
|
Gallardo et al., 2020
|
Islet Amyloid Polypeptide (IAPP) C-term amidated S20G mutant
|
Synthetic
|
15-37
|
cryoEM
|
4.0
|
 |
 |
6zrr
|
Gallardo et al., 2020
|
Islet Amyloid Polypeptide (IAPP), amidated, wild type
| Synthetic, seeded with fibrils from a Type 2 Diabetes Patient, Polymorph 1
| 13-37
| cryoEM
| 3.8
|  |
 |
7m61
|
Cao et al., 2021
|
Islet Amyloid Polypeptide (IAPP), amidated, wild type
| Synthetic, seeded with fibrils from a Type 2 Diabetes Patient, Polymorph 2
| 6-37
| cryoEM
| 3.9
|  |
 |
7m62
|
Cao et al., 2021
|
Islet Amyloid Polypeptide (IAPP), amidated, wild type
| Synthetic, seeded with fibrils from a Type 2 Diabetes Patient, Polymorph 3
| 13-37
| cryoEM
| 4.0
|  |
 |
7m64
|
Cao et al., 2021
|
Islet Amyloid Polypeptide (IAPP), amidated, wild type
| Synthetic, seeded with fibrils from a Type 2 Diabetes Patient, Polymorph 4
| 6-37
| cryoEM
| 4.1
|  |
 |
7m65
|
Cao et al., 2021
|
Light Chain λ1, Antibody
|
extracted from heart of a human with cardiac AL amyloidosis
|
15-105
|
cryoEM
|
4.0
|
 |
 |
6ic3
|
Radamaker et al., 2019
|
Light Chain λ3, Antibody, conformation A
|
extracted from heart of a human with cardiac AL amyloidosis
|
9-49, 60-107
|
cryoEM
|
3.2
|
 |
 |
6z1o
|
Radamaker et al., 2021
|
Light Chain λ3, Antibody, conformation B
|
extracted from heart of a human with cardiac AL amyloidosis
|
9-49, 68-107
|
cryoEM
|
3.4
|
 |
 |
6z1i
|
Radamaker et al., 2021
|
Light Chain λ6, Antibody
|
extracted from heart of a human with amyloid cardiomyopathy
|
1-37, 66-105
|
cryoEM
|
3.3
|
 |
 |
6hud
|
Swuec et al., 2019
|
Orb2
|
extracted from Drosophila brain
|
176-206
|
cryoEM
|
2.6
|
 |
 |
6vps
|
Hervás et al., 2020
|
Prion (hPrP)
|
Recombinant
|
106-145
|
cryoEM
|
3.5
|
 |
 |
6uur
|
Glynn et al., 2020
|
Prion (hPrP)
| Recombinant
| 170-229
| cryoEM
| 2.7
|  |
 |
6lni
|
Wang et al., 2020
|
Prion (hPrP) E196K Inherited Mutation
| Recombinant
| 175-217
| cryoEM
| 3.07
|  |
 |
7dwv
|
Wang et al., 2021
|
Prion Protein (PrP) Syrian hamster, infectious, 263K strain
| Extracted from clinically ill hamster brain
| 95-227
| cryoEM
| 3.14
|  |
 |
7lna
|
Kraus et al., 2021
|
RIPK1+RIPK3
|
Recombinant
|
448-462, 532-549
|
ssNMR
|
N/A
|
 |
 |
5v7z
|
Mompeán et al., 2018
|
RIPK3 human
| Recombinant
| 448-469
| cryoEM
| 4.24
|  |
 |
7da4
|
Wu et al., 2021
|
RIPK3 human
| Recombinant
| 447-475
| ssNMR
| N/A
|  |
 |
7dac
|
Wu et al., 2021
|
Serum Amyloid A, mouse, morphology I
|
extracted from spleen of a mouse with systemic AA amyloidosis
|
1-69
|
cryoEM
|
3.0
|
 |
 |
6dso
|
Liberta et al., 2019
|
Serum Amyloid A, mouse, morphology II
|
extracted from spleen of a mouse with systemic AA amyloidosis
|
1-69
|
cryoEM
|
3.5
|
 |
 |
6zch
|
Bansal et al., 2021
|
Serum Amyloid A, mouse, morphology i
|
Recombinant
|
1-37
|
cryoEM
|
2.73
|
 |
 |
6zcf
|
Bansal et al., 2021
|
Serum Amyloid A, mouse, morphology ii
|
Recombinant
|
1-37
|
cryoEM
|
2.95
|
 |
 |
6zcg
|
Bansal et al., 2021
|
Serum Amyloid A, human
|
extracted from kidney of a human with AA amyloidosis
|
2-55
|
cryoEM
|
2.7
|
 |
 |
6mst
|
Liberta et al., 2019
|
SH3 Domain of PI3-kinase
|
Recombinant
|
1-77
|
cryoEM
|
3.4
|
 |
 |
6r4r
|
Röder et al., 2019
|
Tau 3R+4R, Alzheimer's, Paired Helical Filament
| extracted from brain of a human with Alzheimer's Disease
| 306-378
| cryoEM
| 3.4
|  |
 |
5o3l
|
Fitzpatrick et al., 2017
|
Tau 3R+4R Paired Helical Filament
| Extracted from Alzheimers Patient Brain and Stained with PET ligand APN1607
| 304-330
| cryoEM
| 3.00
|  |
 |
7nrv
|
Shi et al., 2021
|
Tau 3R+4R Paired Helical Filament
| Extracted from PrP Cerebral Amyloid Angiopathy Patient Brain
| 306-378
| cryoEM
| 3.00
|  |
 |
7mkf
|
Hallinan et al., 2021
|
Tau 3R+4R Paired Helical Filament
| Extracted from Gerstmann-Sträussler-Scheinker Patient Brain
| 305-379
| cryoEM
| 3.30
|  |
 |
7mkh
|
Hallinan et al., 2021
|
Tau 3R+4R Paired Helical Filament
| Extracted from Primary Age-Related Tauopathy Patient Brain Case 3
| 304-380
| cryoEM
| 2.76
|  |
 |
7nrq
|
Shi et al., 2021
|
Tau 3R+4R, Alzheimer's, Straight Filament
|
extracted from brain of a human with Alzheimer's Disease
|
306-378
|
cryoEM
|
3.4
|
 |
 |
5o3t
|
Fitzpatrick et al., 2017
|
Tau 3R+4R Straight Filament
| Extracted from Alzheimers Patient Brain and Stained with PET ligand APN1607
| 304-380
| cryoEM
| 3.55
|  |
 |
7nrx
|
Shi et al., 2021
|
Tau 3R+4R Straight Filament
| Extracted from PrP Cerebral Amyloid Angiopathy Patient Brain
| 306-378
| cryoEM
| 3.07
|  |
 |
7mkg
|
Hallinan et al., 2021
|
Tau 3R+4R Straight Filament Conformation 1
| Extracted from Primary Age-Related Tauopathy Patient Brain Case 3
| 304-380
| cryoEM
| 2.68
|  |
 |
7nrs
|
Shi et al., 2021
|
Tau 3R+4R Straight Filament Conformation 2
| Extracted from Primary Age-Related Tauopathy Patient Brain Case 3
| 304-380
| cryoEM
| 2.68
|  |
 |
7nrt
|
Shi et al., 2021
|
Tau 3R, Pick's
|
extracted from brain of a human with Pick's Disease
|
254-378 Δ275-305
|
cryoEM
|
3.2
|
 |
 |
6gx5
|
Falcon et al., 2018
|
Tau 4R, CTE Type 1
|
extracted from brain of a human with Chronic Traumatic Encephalopathy
|
305-379
|
cryoEM
|
2.3
|
 |
 |
6nwp
|
Falcon et al., 2019
|
Tau 4R, CTE Type 2
|
extracted from brain of a human with Chronic Traumatic Encephalopathy
|
305-379
|
cryoEM
|
3.4
|
 |
 |
6nwq
|
Falcon et al., 2019
|
Tau 4R, CBD Type 1
|
extracted from brain of a human with Corticobasal Degeneration
|
274-380
|
cryoEM
|
3.2
|
 |
 |
6tjo
|
Zhang et al., 2020
|
Tau 4R, CBD Type 2
|
extracted from brain of a human with Corticobasal Degeneration
|
274-380
|
cryoEM
|
3.0
|
 |
 |
6tjx
|
Zhang et al., 2020
|
Tau 4R AGD Filament Type 1
| Extracted from Argyrophilic Grain Disease Patient Brain
| 273-387
| cryoEM
| 3.30
|  |
 |
7p6d
|
Shi et al., 2021
|
Tau 4R AGD Filament Type 2
| Extracted from Argyrophilic Grain Disease Patient Brain
| 274-381
| cryoEM
| 3.40
|  |
 |
7p6e
|
Shi et al., 2021
|
Tau 4R PSP Filament
| Extracted from Progressive Supranuclear Palsy Patient Brain
| 272-381
| cryoEM
| 2.70
|  |
 |
7p65
|
Shi et al., 2021
|
Tau 4R Filament GGT Type 1
| Extracted from Globular Glial Tauopathy Patient Brain
| 272-379
| cryoEM
| 3.00
|  |
 |
7p66
|
Shi et al., 2021
|
Tau 4R Filament GGT Type 2
| Extracted from Globular Glial Tauopathy Patient Brain
| 272-379
| cryoEM
| 3.10
|  |
 |
7p67
|
Shi et al., 2021
|
Tau 4R Filament GGT Type 3
| Extracted from Globular Glial Tauopathy Patient Brain
| 272-379
| cryoEM
| 2.90
|  |
 |
7p68
|
Shi et al., 2021
|
Tau 4R Filament LNT Type 1a
| Extracted from Limbic-Predominant Neuronal Inclusion Body 4R Tauopathy Patient Brain
| 272-379
| cryoEM
| 1.90
|  |
 |
7p6a
|
Shi et al., 2021
|
Tau 4R Filament LNT Type 1b
| Extracted from Limbic-Predominant Neuronal Inclusion Body 4R Tauopathy Patient Brain
| 272-379
| cryoEM
| 2.50
|  |
 |
7p6b
|
Shi et al., 2021
|
Tau 4R Filament LNT Type 2
| Extracted from Limbic-Predominant Neuronal Inclusion Body 4R Tauopathy Patient Brain
| 272-379
| cryoEM
| 2.20
|  |
 |
7p6c
|
Shi et al., 2021
|
Tau 4R, Snake Polymorph, Heparin Induced
|
Recombinant
|
272-330
|
cryoEM
|
3.3
|
 |
 |
6qjh
|
Zhang et al., 2019
|
Tau 4R, Twister Polymorph, Heparin Induced
|
Recombinant
|
274-292, 304-321
|
cryoEM
|
3.3
|
 |
 |
6qjm
|
Zhang et al., 2019
|
Tau 4R, Jagged Polymorph, Heparin Induced
|
Recombinant
|
274-290, 304-321
|
cryoEM
|
3.5
|
 |
 |
6qjp
|
Zhang et al., 2019
|
Tau 3R, Heparin Induced
|
Recombinant
|
272-330 Δ275-305
|
cryoEM
|
3.5
|
 |
 |
6qjq
|
Zhang et al., 2019
|
TDP-43 (247-257)
|
synthetic
|
247-257
|
cryoEM
|
3.7
|
 |
 |
5w7v
|
Guenther et al., 2018
|
TDP-43 (311-360)
|
Recombinant
|
312-347
|
cryoEM
|
3.8
|
 |
 |
6n37
|
Cao et al., 2019
|
TDP-43 (311-360)
|
Recombinant
|
312-352
|
cryoEM
|
3.8
|
 |
 |
6n3b
|
Cao et al., 2019
|
TDP-43 (311-360)
|
Recombinant
|
311-360
|
cryoEM
|
3.3
|
 |
 |
6n3a
|
Cao et al., 2019
|
TDP-43 A315E (286-331)
|
Recombinant
|
288-319
|
cryoEM
|
3.3
|
 |
 |
6n3c
|
Cao et al., 2019
|
TDP-43 Low Complexity Domain (267-414)
|
Recombinant
|
276-414
|
cryoEM
|
3.2
|
 |
 |
7kwz
|
Li et al., 2021
|
TDP-43 ALS and FTLD Filament
| Extracted from Patient with Amyotrophic Lateral Sclerosis and Fronto-temporal Lobar Degeneration
| 282-360
| cryoEM
| 2.59
|  |
 |
7py2
|
Arseni et al., 2021
|
Transthyretin V30M
|
extracted from heart of a human with hereditary V30M ATTR Amyloidosis
|
11-35, 57-123
|
cryoEM
|
3.0
|
 |
 |
6sdz
|
Schmidt et al., 2019
|
Transthyretin Filament from ATTR, Eye
| Extracted from the Vitreous Body of the Eye of an Amyloid Transthyretin Amyloidosis Patient
| 11-35, 57-123
| cryoEM
| 3.22
|  |
 |
7ob4
|
Iakovleva et al., 2021
|
